Utility of Far‐Field Potentials as a Biomarker of Neurodegeneration in Spinal Muscular Atrophy

20260 citationsJournal Articlehybrid Open Access

Authors

Aicee Dawn Calma · Concord Hospital

Nathan Pavey · Concord Hospital

Cláudia Santos Silva · Concord Hospital

Y Tsuji · Concord Hospital

Amirul Ab Ghapar · Ministry of Health

Katrina Morris · Concord Hospital

Matthew C. Kiernan ·

Abstract

FFP amplitude appears to be a promising neurophysiological biomarker for SMA, with potential utility for monitoring disease progression, particularly in a clinical trial setting.

Topics & Keywords

Neurogenetic and Muscular Disorders Research Muscle activation and electromyography studies Amyotrophic Lateral Sclerosis Research

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Muscle & Nerve

DOI: 10.1002/mus.70231

Field-Weighted Citation Impact: 0.00